Why HPP Stock dropped -4.96% Today — RQD Quant Desk Flash

Per the Roarable RQD rating, HPP scores 45 out of 100, earning a letter grade of D and the verdict label "Roarable Sell — Underperform / Distribution Warning." The score is built from five pillars, each scored out of 20:

• Fundamental Cash Engine (10/20): Per the RQD rating, this pillar reflects ROIC of -19.9% and an FCF yield of 20.1%. The negative ROIC indicates the business is not currently earning a return above its cost of capital, while the high FCF yield suggests reported free cash flow is large relative to market capitalization. Investors should weigh these two readings against each other rather than treating the FCF yield alone as a positive signal.
• Whale 13F Flow (8/20): Per the RQD rating, institutional accumulation and options positioning scored weakly. The underlying holder-level detail is not available in source data, so the pillar cannot be decomposed further here.
• Insider Conviction (8/20): Per the RQD rating, SEC Form 4 and Congressional PTR cluster flow scored weakly. No specific insider transactions are itemized in the source data.
• Macro Regime Fit (11/20): Per the RQD rating, beta is 1.0 and the score reflects sector sensitivity. This is the strongest pillar, though still below midpoint.
• Forensic Balance Sheet (8/20): Per the RQD rating, Altman Z-Score is 2.5, Piotroski F-Score is 3 of 9, and Debt/Equity is 0.5. These readings place the balance sheet in a weak-to-middling position on the forensic checks.

Taken together, the pillars describe a stock where cash generation metrics look strong on the surface but are contradicted by negative ROIC, negative net margins, and weak institutional and insider signals. For a prospective investor evaluating the stock today, the rating implies that the case for ownership rests on a recovery in profitability that the current data does not yet show. Upside would depend on returns on invested capital turning positive; valuation tradeoffs are difficult to assess because P/E and EV/EBITDA are not available in source data.

Per the SEC financials, revenue declined from $952.3M in FY 2023 to $842.1M in FY 2024 and $831.1M in FY 2025, while net losses widened from $-170.7M to $-381.4M and then $-592.3M. Reported free cash flow fell from $232.3M to $164.7M and then $121.0M across the same periods. Per the market data, gross and operating margins are reported as 0%, net margin is -60%, ROIC is -19.9%, and FCF yield is 20.1%. Per the RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 3 of 9, with Debt/Equity at 0.5; the balance sheet posture therefore reflects a company with reported cash generation but persistent net losses and a weak forensic profile.

• What are the terms of the $200 million senior notes tender offer, and how does the resulting debt position change leverage and interest burden?
• What drove the widening net losses from FY 2023 through FY 2025, and what is the path to positive ROIC?
• What are the current consensus rating and price targets, and how do they compare with the $11.09 price?
• What do institutional 13F filings and insider Form 4 transactions show in terms of direction and size?
• What are the operating income and debt figures, which are reported as $0.0M and N/A in the financials, and do they reflect source limitations or actual results?